SCHULTES BIRGIT C (EVP, Chief Scientific Officer) received a stock award from INTELLIA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001193125-26-088251
Officer· EVP, Chief Scientific Officer
Since Mar 2026
+95.20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
95.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+39.20K
Price / share
—
Trade value
—
% of position
39.8%
3/1/2026
98.53K→137.73K
Total
Net shares
+39.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +39.20K | — | — | 39.8% | 98.53K | 137.73K |
| Total | +39.20K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
56K shares
Shares
+56K
Strike price
13.78
Held after
56K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock56K shares | 3/1/2026 | A · Award | +56K | 13.78 | — | 56K |